impact factor, citescore
logo
 

shopping cart

Confirmation
purchase
Item
Code
Item DescriptionPrice
CER17644Phase 3, 56-week, randomised, double-blind, placebo-controlled study utilising patient-reported and radiographic outcomes evaluating the efficacy and safety of a lorecivivint injection in patients with moderate to severe knee osteoarthritis: OA-11 Study20.00 €
 Subtotal 20.00 €